Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo
暂无分享,去创建一个
Rolf M. Zinkernagel | Hans Hengartner | Kurt Bürki | Hanspeter Pircher | H. Pircher | R. Zinkernagel | D. Moskophidis | H. Hengartner | K. Bürki | U. Rohrer | Demetrius Moskophidis | Urs Rohrer
[1] H. White,et al. Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes , 1990, Journal of virology.
[2] H. Hengartner,et al. Preferential usage of Vα4 and Vβ10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein‐specific H‐2Db‐restricted cytotoxic T cells , 1990 .
[3] P. Doherty,et al. Dissection of an inflammatory process induced by CD8+ T cells. , 1990, Immunology today.
[4] H. Pircher,et al. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.
[5] K. Klyczek,et al. In vivo generation of antigenic variants of murine retroviruses. , 1989, Virology.
[6] V. Nussenzweig,et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.
[7] P. Fultz,et al. Spectrum of disease in macaque monkeys chronically infected with SIV/SMM. , 1989, Veterinary immunology and immunopathology.
[8] R. Zinkernagel,et al. Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoprotein , 1989, European journal of immunology.
[9] H. Pircher,et al. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. , 1989, The EMBO journal.
[10] D. Moss,et al. Requirements for Recognition of Epstein-Barr Virus-Infected Target Cells by Human Cytotoxic T Lymphocytes , 1989 .
[11] L. Lasky,et al. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. , 1988, Journal of immunology.
[12] M. Vilanova,et al. Correlation between B-cell mitogenicity and immunosuppressor effects of a protein released by porcine monocytes infected with African swine fever virus. , 1988, American journal of veterinary research.
[13] J. Albert,et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates , 1988, Journal of virology.
[14] S. Dewhurst,et al. Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual , 1988, Journal of virology.
[15] David Looney,et al. Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.
[16] J. Whitton,et al. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.
[17] J. Levy,et al. Mysteries of HIV: challenges for therapy and prevention , 1988, Nature.
[18] M. Billeter,et al. Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line , 1988, Journal of virology.
[19] D. Burke,et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.
[20] D. Moskophidis,et al. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response , 1987, Journal of virology.
[21] M. Buchmeier,et al. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. , 1987, Virology.
[22] H. Pircher,et al. Molecular analysis of the antigen receptor of virus‐specific cytotoxic T cells and identification of a new Vα family , 1987 .
[23] H. Pircher,et al. Characterization of virus‐specific cytotoxic T cell clones from allogeneic bone marrow chimeras , 1987, European journal of immunology.
[24] M. Oldstone,et al. Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis , 1986, Journal of virology.
[25] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[26] R. Zinkernagel,et al. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus , 1986, European journal of immunology.
[27] M. Oldstone,et al. Concepts in Viral Pathogenesis II , 1986, Springer New York.
[28] K. McIntyre,et al. Exquisite specificity of adoptive immunization in arenavirus-infected mice. , 1985, Antiviral research.
[29] Y. Matsuura,et al. Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. , 1985, Virus research.
[30] M. Oldstone,et al. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.
[31] P. Marrack,et al. The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype , 1984, The Journal of experimental medicine.
[32] C. Melief,et al. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity , 1983, Nature.
[33] J. F. Young,et al. Variation of influenza A, B, and C viruses. , 1982, Science.
[34] G. Air,et al. Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies. , 1979, Virology.
[35] R. Webster,et al. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule , 1979, Nature.
[36] P. A. Peterson,et al. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[37] H. Koprowski,et al. Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[38] F. Lehmann-Grube,et al. A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera. , 1977, The Journal of general virology.
[39] D. Griffin,et al. Antigenic shift of visna virus in persistently infected sheep. , 1977, Science.
[40] R. Zinkernagel,et al. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. , 1976, Journal of immunology.
[41] C. Mims. The pathogenesis of infectious disease. , 1976 .
[42] F. Lehmann-Grube,et al. Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse. , 1976, The Journal of general virology.
[43] M. Oldstone,et al. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation , 1975, The Journal of experimental medicine.
[44] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[45] R. Webster,et al. Studies on the origin of pandemic influenza. 3. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. , 1973, Virology.
[46] N. Nathanson,et al. Requirement for Θ-Bearing Cells in Lymphocytic Choriomeningitis Virus-induced Central Nervous System Disease , 1972, Nature.
[47] J. G. Stevens,et al. Latent Herpes Simplex Virus in Spinal Ganglia of Mice , 1971, Science.
[48] J. Hotchin. The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. , 1962, Cold Spring Harbor symposia on quantitative biology.